Degree: Bachelor’s of Science degree
Richard Benjamin Libman, MD
Dr. Libman earned a Bachelor’s of Science degree and a medical degree from the McGill University School of Medicine in Montréal, Canada. He completed a residency in neurology at the Albert Einstein College of Medicine and a fellowship in stroke at Columbia Presbyterian Medical Center/New York Neurological Institute.
Dr. Libman is vice chairman of neurology. He joined the health system in 1993 as a stroke neurologist at Long Island Jewish Medical Center. Under his leadership, the hospital became one of the leading centers in the country for clinical trials testing innovative treatments for stroke, including participating in the landmark National Institutes of Health study on the clot-busting drug TPA, which revolutionized the treatment of acute stroke. Under Dr. Libman’s leadership, Long Island Jewish Medical Center won the American Heart Associations’ highest awards for quality of care of stroke patients. In his leadership role of the Northwell Health Task Force, Dr. Libman oversaw the accreditation of all health system hospitals as New York State Department of Health-designated primary stroke centers.
Dr. Libman has published extensively in various neurological and stroke journals and has presented his work at national and international meetings. He is a professor of neurology at the Hofstra Northwell school of medicine, a member of the American Academy of Neurology, American Heart/American Stroke Association and the American Medical Association. He has been given the Teacher of the Year award on several occasions.
Degree: medical degree
Richard Benjamin Libman, MD
Dr. Libman earned a Bachelor’s of Science degree and a medical degree from the McGill University School of Medicine in Montréal, Canada. He completed a residency in neurology at the Albert Einstein College of Medicine and a fellowship in stroke at Columbia Presbyterian Medical Center/New York Neurological Institute.
Dr. Libman is vice chairman of neurology. He joined the health system in 1993 as a stroke neurologist at Long Island Jewish Medical Center. Under his leadership, the hospital became one of the leading centers in the country for clinical trials testing innovative treatments for stroke, including participating in the landmark National Institutes of Health study on the clot-busting drug TPA, which revolutionized the treatment of acute stroke. Under Dr. Libman’s leadership, Long Island Jewish Medical Center won the American Heart Associations’ highest awards for quality of care of stroke patients. In his leadership role of the Northwell Health Task Force, Dr. Libman oversaw the accreditation of all health system hospitals as New York State Department of Health-designated primary stroke centers.
Dr. Libman has published extensively in various neurological and stroke journals and has presented his work at national and international meetings. He is a professor of neurology at the Hofstra Northwell school of medicine, a member of the American Academy of Neurology, American Heart/American Stroke Association and the American Medical Association. He has been given the Teacher of the Year award on several occasions.
Education record: Dr. Libman earned a Bachelor’s of Science degree and a medical degree from the McGill University School of Medicine in Montréal, Canada.
Richard Benjamin Libman, MD
Dr. Libman earned a Bachelor’s of Science degree and a medical degree from the McGill University School of Medicine in Montréal, Canada. He completed a residency in neurology at the Albert Einstein College of Medicine and a fellowship in stroke at Columbia Presbyterian Medical Center/New York Neurological Institute.
Dr. Libman is vice chairman of neurology. He joined the health system in 1993 as a stroke neurologist at Long Island Jewish Medical Center. Under his leadership, the hospital became one of the leading centers in the country for clinical trials testing innovative treatments for stroke, including participating in the landmark National Institutes of Health study on the clot-busting drug TPA, which revolutionized the treatment of acute stroke. Under Dr. Libman’s leadership, Long Island Jewish Medical Center won the American Heart Associations’ highest awards for quality of care of stroke patients. In his leadership role of the Northwell Health Task Force, Dr. Libman oversaw the accreditation of all health system hospitals as New York State Department of Health-designated primary stroke centers.
Dr. Libman has published extensively in various neurological and stroke journals and has presented his work at national and international meetings. He is a professor of neurology at the Hofstra Northwell school of medicine, a member of the American Academy of Neurology, American Heart/American Stroke Association and the American Medical Association. He has been given the Teacher of the Year award on several occasions.
Education record: He completed a residency in neurology at the Albert Einstein College of Medicine and a fellowship in stroke at Columbia Presbyterian Medical Center/New York Neurological Institute.
He completed a residency in neurology at the Albert Einstein College of Medicine and a fellowship in stroke at Columbia Presbyterian Medical Center/New York Neurological Institute.
Identity: Richard Benjamin Libman
Richard Benjamin Libman, MD
Dr. Libman earned a Bachelor’s of Science degree and a medical degree from the McGill University School of Medicine in Montréal, Canada. He completed a residency in neurology at the Albert Einstein College of Medicine and a fellowship in stroke at Columbia Presbyterian Medical Center/New York Neurological Institute.
Dr. Libman is vice chairman of neurology. He joined the health system in 1993 as a stroke neurologist at Long Island Jewish Medical Center. Under his leadership, the hospital became one of the leading centers in the country for clinical trials testing innovative treatments for stroke, including participating in the landmark National Institutes of Health study on the clot-busting drug TPA, which revolutionized the treatment of acute stroke. Under Dr. Libman’s leadership, Long Island Jewish Medical Center won the American Heart Associations’ highest awards for quality of care of stroke patients. In his leadership role of the Northwell Health Task Force, Dr. Libman oversaw the accreditation of all health system hospitals as New York State Department of Health-designated primary stroke centers.
Dr. Libman has published extensively in various neurological and stroke journals and has presented his work at national and international meetings. He is a professor of neurology at the Hofstra Northwell school of medicine, a member of the American Academy of Neurology, American Heart/American Stroke Association and the American Medical Association. He has been given the Teacher of the Year award on several occasions.
Professional role: Dr. Libman is vice chairman of neurology. He joined the health system in 1993 as a stroke neurologist at Long Island Jewish Medical Center. Under his leadership, the hospital became one of the leading centers in the country for clinical trials testing innovative treatments for stroke, including participating in the landmark National Institutes of Health study on the clot-busting drug TPA, which revolutionized the treatment of acute stroke. Under Dr. Libman’s leadership, Long Island Jewish Medical Center won the American Heart Associations’ highest awards for quality of care of stroke patients. In his leadership role of the Northwell Health Task Force, Dr. Libman oversaw the accreditation of all health system hospitals as New York State Department of Health-designated primary stroke centers.
Richard Benjamin Libman, MD
Dr. Libman earned a Bachelor’s of Science degree and a medical degree from the McGill University School of Medicine in Montréal, Canada. He completed a residency in neurology at the Albert Einstein College of Medicine and a fellowship in stroke at Columbia Presbyterian Medical Center/New York Neurological Institute.
Dr. Libman is vice chairman of neurology. He joined the health system in 1993 as a stroke neurologist at Long Island Jewish Medical Center. Under his leadership, the hospital became one of the leading centers in the country for clinical trials testing innovative treatments for stroke, including participating in the landmark National Institutes of Health study on the clot-busting drug TPA, which revolutionized the treatment of acute stroke. Under Dr. Libman’s leadership, Long Island Jewish Medical Center won the American Heart Associations’ highest awards for quality of care of stroke patients. In his leadership role of the Northwell Health Task Force, Dr. Libman oversaw the accreditation of all health system hospitals as New York State Department of Health-designated primary stroke centers.
Dr. Libman has published extensively in various neurological and stroke journals and has presented his work at national and international meetings. He is a professor of neurology at the Hofstra Northwell school of medicine, a member of the American Academy of Neurology, American Heart/American Stroke Association and the American Medical Association. He has been given the Teacher of the Year award on several occasions.
Professional role: He is a professor of neurology at the Hofstra Northwell school of medicine
He is a professor of neurology at the Hofstra Northwell school of medicine
Professional role: professor of neurology
Richard Benjamin Libman, MD
Dr. Libman earned a Bachelor’s of Science degree and a medical degree from the McGill University School of Medicine in Montréal, Canada. He completed a residency in neurology at the Albert Einstein College of Medicine and a fellowship in stroke at Columbia Presbyterian Medical Center/New York Neurological Institute.
Dr. Libman is vice chairman of neurology. He joined the health system in 1993 as a stroke neurologist at Long Island Jewish Medical Center. Under his leadership, the hospital became one of the leading centers in the country for clinical trials testing innovative treatments for stroke, including participating in the landmark National Institutes of Health study on the clot-busting drug TPA, which revolutionized the treatment of acute stroke. Under Dr. Libman’s leadership, Long Island Jewish Medical Center won the American Heart Associations’ highest awards for quality of care of stroke patients. In his leadership role of the Northwell Health Task Force, Dr. Libman oversaw the accreditation of all health system hospitals as New York State Department of Health-designated primary stroke centers.
Dr. Libman has published extensively in various neurological and stroke journals and has presented his work at national and international meetings. He is a professor of neurology at the Hofstra Northwell school of medicine, a member of the American Academy of Neurology, American Heart/American Stroke Association and the American Medical Association. He has been given the Teacher of the Year award on several occasions.
Professional role: stroke neurologist
Richard Benjamin Libman, MD
Dr. Libman earned a Bachelor’s of Science degree and a medical degree from the McGill University School of Medicine in Montréal, Canada. He completed a residency in neurology at the Albert Einstein College of Medicine and a fellowship in stroke at Columbia Presbyterian Medical Center/New York Neurological Institute.
Dr. Libman is vice chairman of neurology. He joined the health system in 1993 as a stroke neurologist at Long Island Jewish Medical Center. Under his leadership, the hospital became one of the leading centers in the country for clinical trials testing innovative treatments for stroke, including participating in the landmark National Institutes of Health study on the clot-busting drug TPA, which revolutionized the treatment of acute stroke. Under Dr. Libman’s leadership, Long Island Jewish Medical Center won the American Heart Associations’ highest awards for quality of care of stroke patients. In his leadership role of the Northwell Health Task Force, Dr. Libman oversaw the accreditation of all health system hospitals as New York State Department of Health-designated primary stroke centers.
Dr. Libman has published extensively in various neurological and stroke journals and has presented his work at national and international meetings. He is a professor of neurology at the Hofstra Northwell school of medicine, a member of the American Academy of Neurology, American Heart/American Stroke Association and the American Medical Association. He has been given the Teacher of the Year award on several occasions.
Official profile: Official profile
Richard Benjamin Libman, MD
Dr. Libman earned a Bachelor’s of Science degree and a medical degree from the McGill University School of Medicine in Montréal, Canada. He completed a residency in neurology at the Albert Einstein College of Medicine and a fellowship in stroke at Columbia Presbyterian Medical Center/New York Neurological Institute.
Dr. Libman is vice chairman of neurology. He joined the health system in 1993 as a stroke neurologist at Long Island Jewish Medical Center. Under his leadership, the hospital became one of the leading centers in the country for clinical trials testing innovative treatments for stroke, including participating in the landmark National Institutes of Health study on the clot-busting drug TPA, which revolutionized the treatment of acute stroke. Under Dr. Libman’s leadership, Long Island Jewish Medical Center won the American Heart Associations’ highest awards for quality of care of stroke patients. In his leadership role of the Northwell Health Task Force, Dr. Libman oversaw the accreditation of all health system hospitals as New York State Department of Health-designated primary stroke centers.
Dr. Libman has published extensively in various neurological and stroke journals and has presented his work at national and international meetings. He is a professor of neurology at the Hofstra Northwell school of medicine, a member of the American Academy of Neurology, American Heart/American Stroke Association and the American Medical Association. He has been given the Teacher of the Year award on several occasions.